Meta-Analysis of Prophylactic Renal Replacement Therapy after Cardiac Catheterization in Patients with Chronic Kidney Disease.
Journal
Anatolian journal of cardiology
ISSN: 2149-2271
Titre abrégé: Anatol J Cardiol
Pays: Turkey
ID NLM: 101652981
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
medline:
22
9
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
ppublish
Résumé
The benefits of prophylactic renal replacement therapy after cardiac catheterization in patients with chronic kidney disease remain unclear. The aim of this study is to confirm the benefit of prophylactic renal replacement therapy after cardiac catheterization. We systematically searched for studies published from inception to December 2022 examining the benefits of prophylactic renal replacement therapy after cardiac catheterization in MEDLINE and EMBASE. Data analysis was performed according to the PRISMA statement using the Mantel-Haenszel method. Five studies met the inclusion criteria, which comprised of 532 chronic kidney disease patients who underwent coronary angiography (268 had prophylactic renal replacement therapy and 264 did not have prophylactic renal replacement therapy). The pooled analysis revealed a non-significant decreased risk of 1-year mortality in chronic kidney disease patients who underwent coronary angiography and prophylactic renal replacement therapy compared to those who did not have prophylactic renal replacement therapy (RR = 0.59; P =.18; CI: 0.28-1.2795, I2 = 60.4%). The risk of hemodialysis during hospitalization and renal replacement therapy requirement in 1 year in chronic kidney disease patients who underwent coronary angiography and prophylactic renal replacement therapy were lower than in those who did not have prophylactic renal replacement therapy (RR = 0.13; P =.001; CI: 0.04-0.43, I2 = 9.1% and RR = 0.29; P =.015; CI: 0.11-0.78, I2 = 49.9%, respectively). The sensitivity analysis demonstrated that the overall findings remained consistent and did not significantly alter. Prophylactic renal replacement therapy did not seem to lower 1-year mortality among chronic kidney disease patients who underwent coronary angiography. However, prophylactic renal replacement therapy appeared to reduce the risk of hemodialysis during hospitalization and renal replacement therapy requirement in 1 year.
Sections du résumé
BACKGROUND
The benefits of prophylactic renal replacement therapy after cardiac catheterization in patients with chronic kidney disease remain unclear. The aim of this study is to confirm the benefit of prophylactic renal replacement therapy after cardiac catheterization.
METHODS
We systematically searched for studies published from inception to December 2022 examining the benefits of prophylactic renal replacement therapy after cardiac catheterization in MEDLINE and EMBASE. Data analysis was performed according to the PRISMA statement using the Mantel-Haenszel method.
RESULTS
Five studies met the inclusion criteria, which comprised of 532 chronic kidney disease patients who underwent coronary angiography (268 had prophylactic renal replacement therapy and 264 did not have prophylactic renal replacement therapy). The pooled analysis revealed a non-significant decreased risk of 1-year mortality in chronic kidney disease patients who underwent coronary angiography and prophylactic renal replacement therapy compared to those who did not have prophylactic renal replacement therapy (RR = 0.59; P =.18; CI: 0.28-1.2795, I2 = 60.4%). The risk of hemodialysis during hospitalization and renal replacement therapy requirement in 1 year in chronic kidney disease patients who underwent coronary angiography and prophylactic renal replacement therapy were lower than in those who did not have prophylactic renal replacement therapy (RR = 0.13; P =.001; CI: 0.04-0.43, I2 = 9.1% and RR = 0.29; P =.015; CI: 0.11-0.78, I2 = 49.9%, respectively). The sensitivity analysis demonstrated that the overall findings remained consistent and did not significantly alter.
CONCLUSIONS
Prophylactic renal replacement therapy did not seem to lower 1-year mortality among chronic kidney disease patients who underwent coronary angiography. However, prophylactic renal replacement therapy appeared to reduce the risk of hemodialysis during hospitalization and renal replacement therapy requirement in 1 year.
Identifiants
pubmed: 37599634
doi: 10.14744/AnatolJCardiol.2023.3443
pmc: PMC10510418
doi:
Types de publication
Systematic Review
Meta-Analysis
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
504-512Références
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
EuroIntervention. 2019 Feb 20;14(14):1435-1534
pubmed: 30667361
J Am Soc Nephrol. 2019 Jun;30(6):1086-1095
pubmed: 31053638
Catheter Cardiovasc Interv. 2003 Jan;58(1):59-64
pubmed: 12508197
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
Am J Nephrol. 2000 Jul-Aug;20(4):300-4
pubmed: 10970983
N Engl J Med. 2003 Feb 6;348(6):491-9
pubmed: 12571256
J Formos Med Assoc. 2021 Jan;120(1 Pt 3):629-640
pubmed: 32709451
Int J Cardiol. 2005 Jun 8;101(3):407-13
pubmed: 15907408
Am J Kidney Dis. 2002 May;39(5):930-6
pubmed: 11979336
Crit Pathw Cardiol. 2018 Mar;17(1):25-31
pubmed: 29432373
J Clin Epidemiol. 2001 Oct;54(10):1046-55
pubmed: 11576817
N Engl J Med. 2003 Oct 2;349(14):1333-40
pubmed: 14523141
Catheter Cardiovasc Interv. 2001 Apr;52(4):409-16
pubmed: 11285590
J Am Coll Cardiol. 2001 Oct;38(4):963-8
pubmed: 11583865
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Lancet. 2003 Jan 4;361(9351):13-20
pubmed: 12517460
Ann Intern Med. 2002 Oct 1;137(7):563-70
pubmed: 12353943
Am J Med. 1997 Nov;103(5):368-75
pubmed: 9375704
N Engl J Med. 1997 May 1;336(18):1303-9
pubmed: 9113935
Nephrol Dial Transplant. 1997 Dec;12(12):2597-602
pubmed: 9430858
Acta Radiol. 1996 Sep;37(5):826-9
pubmed: 8915301
J Am Coll Cardiol. 2007 Sep 11;50(11):1015-20
pubmed: 17825709
Circulation. 2002 May 14;105(19):2259-64
pubmed: 12010907
J Am Coll Cardiol. 2004 Nov 2;44(9):1780-5
pubmed: 15519007
Am J Nephrol. 2010;32(5):497-504
pubmed: 20975263
Catheter Cardiovasc Interv. 2022 Jul;100(1):85-93
pubmed: 35500170
Kidney Int Suppl. 2006 Apr;(100):S51-3
pubmed: 16612402
Rev Cardiovasc Med. 2003;4 Suppl 5:S3-9
pubmed: 14668704
N Engl J Med. 1992 Feb 13;326(7):425-30
pubmed: 1732769
Am J Med. 1989 Jun;86(6 Pt 1):649-52
pubmed: 2729314
Lancet. 2003 Aug 23;362(9384):598-603
pubmed: 12944058
N Engl J Med. 1994 Nov 24;331(21):1416-20
pubmed: 7969280
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228
pubmed: 25260718
Semin Dial. 2009 Mar-Apr;22(2):173-9
pubmed: 19426424
N Engl J Med. 1999 Nov 4;341(19):1413-9
pubmed: 10547403
Arzneimittelforschung. 1990 Jul;40(7):830-2
pubmed: 2222559
Am J Cardiol. 2006 Sep 18;98(6A):14K-20K
pubmed: 16949376
Am J Cardiol. 2014 Feb 15;113(4):588-92
pubmed: 24321895
N Engl J Med. 2006 Jun 29;354(26):2773-82
pubmed: 16807414
N Engl J Med. 2019 May 30;380(22):2146-2155
pubmed: 31141635
Eur Radiol. 2002 Dec;12(12):3026-30
pubmed: 12439587
N Engl J Med. 1989 Jan 19;320(3):149-53
pubmed: 2643042
Catheter Cardiovasc Interv. 2015 Feb 15;85(3):345-51
pubmed: 25307697
Nephron. 1990;56(1):81-5
pubmed: 2234253